Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bassler Bonnie L Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 1,384 shares @ $27.0775, valued at $37.5k
08/23/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 853 shares @ $829, valued at $707.1k
Exercised 853 options to buy @ $391.92, valued at $334.3k
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 853 shares @ $789, valued at $673k
Exercised 853 options to buy @ $391.92, valued at $334.3k
08/10/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 1,208 shares @ $31.0273, valued at $37.5k
03/31/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 1,049 shares @ $35.7276, valued at $37.5k
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 1,021 shares @ $779, valued at $795.4k
Exercised 1,021 options to buy @ $380.95, valued at $388.9k
01/05/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 165 shares @ $0
Granted 1,929 options to buy @ $725.89, valued at $1.4M
01/03/2023 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 943 shares @ $39.7613, valued at $37.5k
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/12/2022 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 1,279 shares @ $705, valued at $901.7k
Sold 1,279 shares @ $686.99, valued at $878.7k
Sold 609 shares @ $741, valued at $451.3k
Exercised 609 options to buy @ $376.69, valued at $229.4k
Exercised 1,279 options to buy @ $391.92, valued at $501.3k
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/11/2022 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 1,240 shares @ $725, valued at $899k
Exercised 1,240 options to buy @ $380.95, valued at $472.4k
04/01/2022 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 964 shares @ $38.8703, valued at $37.5k
04/01/2022 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 1,240 shares @ $700, valued at $868k
Exercised 1,240 options to buy @ $380.95, valued at $472.4k
01/05/2022 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 191 shares @ $0
Granted 2,707 options to buy @ $625.6, valued at $1.7M
01/03/2022 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 958 shares @ $39.1051, valued at $37.5k
09/30/2021 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 992 shares @ $37.8016, valued at $37.5k
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/06/2021 4 Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 2,559 shares @ $600, valued at $1.5M
Exercised 2,559 options to buy @ $391.92, valued at $1M
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Bassler Bonnie L (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
06/30/2021 4 Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 871 shares @ $43.0416, valued at $37.5k
06/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2021 4 Bassler Bonnie L (Director) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $2.51, valued at $87.9k
01/25/2021 3 Bassler Bonnie L (Director) has filed a Form 3 on Cidara Therapeutics, Inc.
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy